Approval · Notice of Compliance 4276 · 1996
EXOSURF: Notice of Compliance 4276
Issued April 10, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4276
- Date
- April 10, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Synthetic lung surfactant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXOSURF | 02038269 | — |
| EXOSURF | 01974521 | — |
| EXOSURF | 01927175 | Cancelled Post Market |
Medicinal ingredients
- COLFOSCERIL PALMITATE 67.5 MG per VIAL
- COLFOSCERIL PALMITATE 108 MG per VIAL